PATENT CLAIM ANALYSIS

Application Number: 16361649
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "331000"]

Abstract:
Disclosed herein are methods, formulations, and kits for treating or preventing a heart condition, e.g., cardiac arrhythmia, e.g., atrial arrhythmia, using selective β1 adrenergic receptor blockers. Also disclosed herein are methods, formulations, and kits for treating a heart condition via inhalation or intranasal spray administration of selective β1 adrenergic receptor blocker and class I antiarrhythmic agent.

Claim (Index 23):
The method of  claim 2 , wherein said \u03b21-selective adrenergic receptor blocker is administered at a concentration of about 2 mg/mL to about 30 mg/mL.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.71795
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15976516', '14632252', '15928851', '15422053', '15333953']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8232399102666501
- 35 USC 102 Novelty (BERT): 0.5542648562790422
- Combined Prediction Score: 0.7963424048678893
- Mean Citation Score: 359.47774
- Max Citation Score: 441.52908
- Similarity Product: 256.6008073169661

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test